Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

Treatment Resistant ◽

Resistant Depression ◽

Faculty Opinions recommendation of Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2203956.1814054 ◽

2010 ◽

Author(s):

Randal Dull ◽

Scott Tadler

Keyword(s):

Repeated Dose ◽

Treatment Resistant ◽

Safety And Efficacy ◽

Resistant Depression ◽

Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series

American Journal of Geriatric Psychiatry ◽

10.1016/j.jagp.2020.12.032 ◽

2021 ◽

Author(s):

Orly Lipsitz ◽

Joshua D. Di Vincenzo ◽

Nelson B. Rodrigues ◽

Danielle S. Cha ◽

Yena Lee ◽

...

Keyword(s):

Older Adults ◽

Real World ◽

Case Series ◽

Treatment Resistant ◽

Resistant Depression ◽

Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial

Neuropsychopharmacology ◽

10.1038/s41386-021-01242-9 ◽

2021 ◽

Author(s):

Marijn Lijffijt ◽

Nicholas Murphy ◽

Sidra Iqbal ◽

Charles E. Green ◽

Tabish Iqbal ◽

...

Keyword(s):

Late Life ◽

Optimal Dose ◽

Treatment Resistant ◽

Adaptive Randomization ◽

Resistant Depression ◽

Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2018.0030 ◽

2018 ◽

Vol 28 (7) ◽

pp. 437-444 ◽

Cited By ~ 14

Author(s):

Kathryn R. Cullen ◽

Palistha Amatya ◽

Mark G. Roback ◽

Christina Sophia Albott ◽

Melinda Westlund Schreiner ◽

...

Keyword(s):

Treatment Resistant ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Resistant Depression ◽

Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial

American Journal of Psychiatry ◽

10.1176/appi.ajp.2020.20010018 ◽

2021 ◽

pp. appi.ajp.2020.2

Author(s):

Jennifer B. Dwyer ◽

Angeli Landeros-Weisenberger ◽

Jessica A. Johnson ◽

Amalia Londono Tobon ◽

José M. Flores ◽

...

Keyword(s):

Controlled Trial ◽

Treatment Resistant ◽

Adolescent Treatment ◽

Resistant Depression ◽

Esketamine nasal spray combined with an oral antidepressant for relapse prevention in treatment-resistant depression: results of a double-blind, randomized withdrawal, multicenter study (sustain-1)

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2018.11.1076 ◽

2019 ◽

Vol 29 ◽

pp. S92

Author(s):

E.J. Daly ◽

M. Trivedi ◽

A. Janik ◽

H. Li ◽

Y. Zhang ◽

...

Keyword(s):

Nasal Spray ◽

Multicenter Study ◽

Relapse Prevention ◽

Treatment Resistant ◽

Double Blind ◽

Resistant Depression

Augmentation Therapy With Serial Intravenous Ketamine Over 18 Months in a Patient With Treatment Resistant Depression

Clinical Neuropharmacology ◽

10.1097/wnf.0000000000000104 ◽

2015 ◽

Vol 38 (5) ◽

pp. 212-216 ◽

Cited By ~ 7

Author(s):

Sameer Hassamal ◽

Margaret Spivey ◽

Ananda K. Pandurangi

Keyword(s):

Augmentation Therapy ◽

Treatment Resistant ◽

Resistant Depression ◽

Next-Step Treatment Considerations for Patients With Treatment-Resistant Depression That Responds to Low-Dose Intravenous Ketamine

FOCUS The Journal of Lifelong Learning in Psychiatry ◽

10.1176/appi.focus.20190048 ◽

2020 ◽

Vol 18 (2) ◽

pp. 181-192

Author(s):

William V. Bobo ◽

Patricio Riva-Posse ◽

Fernando S. Goes ◽

Sagar V. Parikh

Keyword(s):

Low Dose ◽

Treatment Resistant ◽

Treatment Considerations ◽

Resistant Depression ◽

A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression

American Journal of Psychiatry ◽

10.1176/appi.ajp.2016.16010037 ◽

2016 ◽

Vol 173 (8) ◽

pp. 816-826 ◽

Cited By ~ 188

Author(s):

Jaskaran B. Singh ◽

Maggie Fedgchin ◽

Ella J. Daly ◽

Peter De Boer ◽

Kimberly Cooper ◽

...

Keyword(s):

Treatment Resistant ◽

Dose Frequency ◽

Double Blind ◽

Resistant Depression ◽

Real clinical setting intravenous ketamine use for treatment resistant depression: 12 month follow-up after initial response

Revista de Psiquiatría y Salud Mental (English Edition) ◽

10.1016/j.rpsmen.2021.11.004 ◽

2021 ◽

Vol 14 (4) ◽

pp. 227-229

Author(s):

Nora Olazabal ◽

Sonia Bustamante ◽

M. Aranzazu Madrazo ◽

Luis Osa ◽

Ana M. O’Neill of Tyrone ◽

...

Keyword(s):

Clinical Setting ◽

Initial Response ◽

Treatment Resistant ◽

Resistant Depression ◽